Heregulin, a new interactor of the telosome/shelterin complex in human telomeres.

Javier A Menendez, Louisa Benboudjema, Luciano Vellon, Miguel A Rubio, Ingrid Espinoza, Judith Campisi, Ruth Lupu

Journal: Oncotarget 2016;6(37):39408-21

PMID: 26327598

Abstract

Telomere length, shape and function depend on a complex of six core telomere-associated proteins referred to as the telosome or shelterin complex. We here demonstrate that the isoform β2 of the heregulin family of growth factors (HRGβ2) is a novel interactor of the telosome/shelterin complex in human telomeres. Analysis of protein-protein interactions using a high-throughput yeast two-hybrid (Y2H) screen identified RAP1, the only telomere protein that is conserved from yeasts to mammals, as a novel interacting partner of HRGβ2. Deletion analysis of RAP1 revealed that the linker domain, a region previously suggested to recruit negative regulators of telomere length, interacts specifically with HRGβ2. Co-immunoprecipitation and imaging experiments demonstrated that, in addition to RAP1, HRGβ2 could associate with the RAP1-associated telomeric repeat binding factor 2 (TRF2). Deletion analysis of HRGβ2 confirmed that a putative nuclear localization signal (NLS) was necessary for nuclear HRGβ2 to exert a negative regulation of telomere length whereas the N-terminus (extracellular) amino acids of HRGβ2 were sufficient to interact with RAP1/TRF2 and promote telomere shortening. Taken together, our studies identify nuclear HRGβ2 as one of the previously unknown regulators predicted to be recruited by the RAP1 linker domain to negatively regulate telomere length in human cells. Our current findings reveal that a new, but likely not the last, unexpected visitor has arrived to the "telosome/shelterin town".

Address: ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism & Cancer Group, Catalan Institute of Oncology (ICO), Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), Girona, Spain.; Evanston Northwestern Healthcare Research Institute, Evanston, IL, USA.; IBYME, CONICET-Laboratorio de Immunohematología, Buenos Aires, Argentina.; Laboratory of Hematology Service, Institut d'Investigació Biomèdica Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Department of Biochemistry, University of Mississippi, Jackson, MS, USA.; Cancer Institute, University of Mississippi, Jackson, MS, USA.; Lawrence Berkeley National Laboratory, Life Sciences Division, Berkeley, CA, USA.; Buck Institute for Research on Aging, Novato, CA, USA.; Mayo Clinic, Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Rochester, MN, USA.; Mayo Clinic Cancer Center, Rochester, MN, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.